Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Walgreens stock pays a rich yield of 6.4% -- more than three times the S&P 500's 1.7% payout. While that may be tempting, Walgreens' financials haven't been strong in recent quarters.

3 Numbers That Could Make You Think Twice About Walgreens' Dividend

Vitamin Angels & Walgreens set to increase access to prenatal vitamins for 50% of underserved pregnant people in the U.S. by 2024. GOLETA, Calif.

VITAMIN ANGELS AND WALGREENS ANNOUNCE EXPANSION OF PRENATAL PILOT PROGRAM TO 12 ADDITIONAL MARKETS; NEARLY 400 WALGREENS STORES NATIONWIDE

AGNC Investment

Amazon

Dollar General

FedEx

Home Depot

Realty Income Corp

STAG Industrial

Walmart

Family spending can be planned out in advance, until circumstances say otherwise. Dividend stocks can help provide growth and income, and monthly stocks can smooth the cash stream.

How Monthly Dividends From Passive Income Stocks Can Help Activate Your Family Budget

Automatic Data Processing

Albemarle

Cincinnati Financial

Clorox

Essex Property Trust

Federal Realty Investment Trust

Hormel Foods

Medtronic

Stanley Black & Decker

Sysco

Target

T. Rowe Price Group

V.F.

Dividend aristocrats are struggling in 2023, with the ProShares S&P 500 Dividend Aristocrats ETF down 4.71% in May. Three strategies for identifying winning aristocrats include focusing on undervalued stocks, fastest expected growth, and a blend of the two. Despite recent underperformance, long-term investors can find value in dividend aristocrats, as they have historically outperformed the S&P 500 index.

My Best Dividend Aristocrats For June 2023

Disney

Buying stocks and purchasing homes are similar in some ways. For example, homebuyers want to buy a house at a cheap price, but they get suspicious if the price is too low.

3 ‘Bargain Stocks' You Better Avoid at All Costs

Walgreens just settled out of court in another opioid prescription lawsuit. It could pay out a big chunk of change to Humana, too, for other reasons.

Walgreens Just Got Another Piece of Bad News -- Should You Sell Its Stock?

Walgreens Boots Alliance is trimming its corporate headcount, doing away with hundreds of jobs. The reductions were first reported by the Chicago Sun-Times.

Walgreens Boots Alliance cutting hundreds of corporate jobs

Walgreens Boots Alliance Inc said on Friday it would slash its corporate staff by about 10%, as it streamlines operations and focuses on consumer-facing healthcare businesses.

Pharmacy chain Walgreens Boots Alliance to cut corporate jobs by 10%

Many analysts on Wall Street are highly optimistic about Walgreens' prospects. However, the company faces some big challenges.

Wall Street Expects This Stock to Skyrocket 30%. Is That Realistic?

Intel

Visa

The Dow Jones outperformed the other major U.S. stock indexes in 2022. Three industry-leading Dow components check all the appropriate boxes for patient investors.

3 Iconic Dow Stocks That Can Safely Double Your Money by 2028

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens is pleased to announce the winners and finalists for our 13th annual Expressions by Walgreens art challenge. The national contest provides monetary awards to winning high school student submissions from around the country. Eligible entries are judged in four categories including visual arts, media arts, spoken word and creative writing. Additionally, prizes are presented to student submissions earning the most online votes in each category and to Teac.

Walgreens Announces Winners for the 2023 Expressions by Walgreens Art Challenge

Diamondback Energy

Kraft Heinz

It makes sense. The tech-heavy Nasdaq-100 consists largely of cyclical companies that prefer to reinvest profits in growth projects instead of paying them out as dividends.

Meet the Nasdaq's 3 Biggest Dividend Payers

Fertnig/iStock via Getty Images Discussing the escalating concerns from Target (NYSE:TGT ) and other chain stores about how "shrinkage" is hitting profit margins. Listen to Wall Street Breakfast on the go on Apple Podcasts and Spotify 0:15 - Why is "shrinkage" a big concern now?

Retailers Face 'Normalized' Organized Theft Escalation

The original class-action lawsuit alleged that Walgreens knew Theranos' tests were "unreliable."

Walgreens And Theranos Reach Settlement With Consumers Who Took Faulty Tests

Humana

National retail pharmacy giant Walgreen Co has asked a U.S. judge to vacate an arbitrator's award of more than $642 million to Humana Health Plan Inc in a drug-pricing dispute, calling the "staggering" sum the result of a "miscarriage of justice."

Walgreens fights 'staggering' $642 mln arbitration award to Humana

Walgreens Boots Alliance ( WBA , Financial) is a holding company that is engaged in retail pharmacy and health care. The company has three reportable segments: U.S. Retail Pharmacy, International and U.S. Healthcare.

Why Walgreens Looks Undervalued

Looking at a slightly longer term, WBA stock is down 46% from levels seen in late 2019.

Is Walgreens Stock Undervalued At $32?

CVS Health

CVS isn't going to provide clinical trial services anymore, but Walgreens will. Walgreens is just as well-equipped as CVS was to compete in the services market.

Can Walgreens Succeed in This Market Where CVS Failed?

American Express

Caterpillar

Johnson & Johnson

JPMorgan Chase & Co

UnitedHealth Group

If you're looking to build a portfolio of high-quality blue chip stocks, Dow stocks should be at or near the top of your list. These stocks, aka the components of the Dow Jones Industrial Average (or DJIA), represent 30 of America's largest, most venerable companies, across multiple sectors.

7 High-Quality Dow Stocks to Buy on the Dip

Dividend payments can be an important source of income for investors. For retirees, dividend payments can help replace employment earnings and supplement pension income.

3 Dividend Aristocrat Stocks to Buy on Sale Right Now

Walgreens now offers one of the highest dividends in its history at 6.12%. The company's U.S. Healthcare segment is growing quickly with sales up 30% YoY on a pro forma basis and the operating margin improving from -40.2% to -28.9%.

Walgreens: Healthcare Might Shock This One Back To Life

San Francisco said on Wednesday it reached a $230 million settlement with Walgreens Boots Alliance Inc over its role in the city's opioid epidemic.

Walgreens reaches $230 million opioid settlement with San Francisco

Nordstrom

NIKE

Starbucks

When REI announced plans in April to close one of its best-performing stores, a location in downtown Portland, Ore., the sporting-goods retailer became the latest to cite shoplifting and higher crime as among the main reasons.

Retailers say theft cost nearly $100 billion last year. But are stores using crime stats to cover up other problems?

Walgreens reaches $230 mln opioid settlement with San Francisco

DEERFIELD, Ill.--(BUSINESS WIRE)--To honor the service and sacrifices of Americans who served in the armed forces, Walgreens is offering a weekend Memorial Day discount to all veterans, active-duty military personnel and their immediate family members, including the families of those who lost their lives in service to their country. Beginning May 26 through May 29, customers with a myWalgreens membership and valid military ID or proof of service will receive 20 percent off regularly priced prod.

Walgreens Honors Veterans, Active Duty Military and Their Families in Honor of Memorial Day with Weekend Discount from Friday, May 26 through Monday, May 29

News for Walgreens Stock (WBA)